Ribose-modified nucleosides as ligands for adenosine receptors:: Synthesis, conformational analysis, and biological evaluation of 1′-C-methyl adenosine analogues

被引:36
作者
Cappellacci, L
Barboni, G
Palmieri, M
Pasqualini, M
Grifantini, M
Costa, B
Martini, C
Franchetti, P [1 ]
机构
[1] Univ Camerino, Dipartimento Sci Chim, I-62032 Camerino, Italy
[2] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy
关键词
D O I
10.1021/jm0102755
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1'-C-Methyl analogues of adenosine and selective adenosine A, receptor agonists, such as N-[(1R)-1-methyl-2-phenylethyl]adenosine ((R)-PIA) and N-6-cyclopentyladenosine, were synthesized to further investigate the subdomain that binds the ribose moiety. Binding affinities of these new compounds at A(1) and A(2A) receptors in rat brain membranes and at A(3) in rat testis membranes were determined and compared. It was found that the 1'-C-methyl modification in adenosine resulted in a decrease of affinity, particularly at A(1) and A(2A) receptors. When this modification was combined with N-6 substitutions with groups that induce high potency and selectivity at A(3) receptors, the high affinity was in part restored and the selectivity was increased. The most potent compound proved to be the V-C-methyl analogue of (R)-PIA with a K-i of 23 nM for the displacement of [H-3]CHA binding from rat brain A(1) receptors and a >435-fold selectivity over A(2A) receptors. In functional assays, these compounds inhibited forskolin-stimulated adenylate cyclase with IC50 values ranging from 0.065 to 3.4 muM, acting as full agonists. Conformational analysis based on vicinal proton-proton J-coupling constants and molecular mechanics calculations using the MM2 force field proved that the methyl group on C1' in adenosine has a pronounced impact on the furanose conformation by driving its conformational equilibrium toward the north, gamma+, syn form.
引用
收藏
页码:1196 / 1202
页数:7
相关论文
共 30 条
  • [1] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [2] CHITTENDEN GJF, 1986, RECL TRAV CHIM PAY B, V105, P186
  • [3] Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway
    Clancy, JP
    Ruiz, FE
    Sorscher, EJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (02): : C361 - C369
  • [4] Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia:: I.: Adenosine agonists
    Dixon, DA
    Fenix, LA
    Kim, DM
    Raffa, RB
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (04) : 480 - 488
  • [5] SYNTHESIS OF THYMINE NUCLEOSIDES DERIVED FROM 1-DEOXY-D-PSICOFURANOSE
    FAIVREBUET, V
    GROUILLER, A
    DESCOTES, G
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1992, 11 (09): : 1651 - 1660
  • [6] Feoktistov I, 1999, MOL PHARMACOL, V55, P726
  • [7] 2′-C-methyl analogues of selective adenosine receptor agonists:: Synthesis and binding studies
    Franchetti, P
    Cappellacci, L
    Marchetti, S
    Trincavelli, L
    Martini, C
    Mazzoni, MR
    Lucacchini, A
    Grifantini, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (10) : 1708 - 1715
  • [8] Adenosine A3 receptors:: novel ligands and paradoxical effects
    Jacobson, KA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) : 184 - 191
  • [9] Jacobson Kenneth A., 1995, Drugs of the Future, V20, P689
  • [10] JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888